Acute and subacute hepatic failure with coma
ICD-10 K72.01 is a billable code used to indicate a diagnosis of acute and subacute hepatic failure with coma.
Acute and subacute hepatic failure with coma is a severe condition characterized by the rapid deterioration of liver function, leading to hepatic encephalopathy and altered mental status. The liver, a vital organ responsible for detoxification, protein synthesis, and metabolic regulation, becomes unable to perform its functions due to acute injury or chronic disease exacerbation. Clinical presentation may include jaundice, coagulopathy, and hepatic encephalopathy, which can progress to coma. The disease can be caused by various factors, including viral hepatitis, drug-induced liver injury, or ischemic liver damage. Diagnosis typically involves clinical evaluation, laboratory tests (such as liver function tests), and imaging studies to assess liver structure and function. Early identification and management are crucial to prevent irreversible damage and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K72.01 covers acute and subacute hepatic failure characterized by significant liver dysfunction leading to coma. This includes conditions such as fulminant hepatic failure and acute liver failure due to various etiologies, including viral hepatitis, drug toxicity, and metabolic disorders.
K72.01 should be used when the patient presents with acute or subacute hepatic failure accompanied by coma. It is crucial to differentiate this from K72.00, which does not include coma, to ensure accurate representation of the severity of the patient's condition.
Documentation for K72.01 should include clinical notes indicating the patient's mental status, laboratory results showing liver function impairment, and evidence of hepatic encephalopathy. Additionally, any imaging studies or consultations that support the diagnosis should be included.
